Sanofi (SAN FP) CEO expects a slightly softer vaccine uptake rate this year; expects flu-Covid combo vaccines in 2027-2028 to drive next surge in vaccine uptake

Sanofi's CEO has indicated an anticipated decline in vaccine uptake this year, which could signal challenges for short-term revenue projections.

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

NY Fed RRP op demand at USD 3.2bln (prev. 3.3bln) across 15 counterparties (prev. 5)

EU's Economic Committee considers ECB's Kazaks and ECB's Centeno as preferred candidates for ECB's VP role

Sanofi (SAN FP) CEO expects a slightly softer vaccine uptake rate this year; expects flu-Covid combo vaccines in 2027-2028 to drive next surge in vaccine uptake

EU parliament leaders call on EU Commission and council to define concrete and tangible support to Greenland and Denmark

Users report service issues with Verizon (VZ), T-Mobile (TMUS) and AT&T (T), according to Downdetector

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

However, the expectation of a new surge driven by flu-Covid combination vaccines by 2027-2028 suggests a longer-term growth opportunity, potentially influencing investor sentiment as they gauge how this impacts Sanofi's pipeline and competitive positioning in the pharma space.

Related headlines

The whole workspace, free to try.

Try it free